4//SEC Filing
Dittrich Thomas J.W. 4
Accession 0001127602-13-018291
CIK 0000318154other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:18 PM ET
Size
16.3 KB
Accession
0001127602-13-018291
Insider Transaction Report
Form 4
AMGEN INCAMGN
Dittrich Thomas J.W.
VP, Finance & CAO
Transactions
- Exercise/Conversion
Nqso (Right to Buy)
2013-05-22−2,150→ 2,150 totalExercise: $58.43From: 2011-04-26Exp: 2020-04-26→ Common Stock (2,150 underlying) - Exercise/Conversion
Common Stock
2013-05-22$50.44/sh+2,000$100,880→ 18,733 total - Exercise/Conversion
Common Stock
2013-05-22$58.43/sh+2,150$125,625→ 20,883 total - Exercise/Conversion
Common Stock
2013-05-22$54.69/sh+1,980$108,286→ 22,863 total - Sale
Common Stock
2013-05-22$104.78/sh−6,130$642,296→ 16,733 total - Exercise/Conversion
Nqso (Right to Buy)
2013-05-22−2,000→ 0 totalExercise: $50.44From: 2010-04-28Exp: 2016-04-28→ Common Stock (2,000 underlying) - Exercise/Conversion
Nqso (Right to Buy)
2013-05-22−1,980→ 4,020 totalExercise: $54.69From: 2013-04-25Exp: 2021-04-25→ Common Stock (1,980 underlying)
Footnotes (3)
- [F1]The price reported is an average price. The prices ranged from $104.7601 to $104.83 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
- [F2]The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001491654
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:18 PM ET
- Size
- 16.3 KB